AFP and hepatocellular carcinoma: Given the seemingly important role of AFP response as a predictor of ORR, PFS, and OS in unresectable HCC, Teng et al. developed a 50-10 rule of AFP responses to predict the prognosis of nivolumab-treated HCC patients, including delayed AFP responders.